Tobias Polak

Appendices 276 9. June 29, 2022. BioBusiness Summer School, Amsterdam University, Amsterdam, The Netherlands. Title: Expanded Access. Invited Speaker. 10. June 1, 2022. CQM Seminar Department of Biostatistics and Epidemiology, Erasmus University Rotterdam. Rotterdam, The Netherlands. Title: “The use of Propensity Scores in Dynamic Borrowing”. Internal Seminar Series. 11. February 2, 2022. Hansen Wade – Operationalize Expanded Access Programs. Virtual (online). Title: Collecting Real-World Data. Panelist. 12. October 11, 2022. Harvard MIT Center for Regulatory Science – Global Conference on Regulatory Science. Virtual (online) ‘Exploring the perspectives of global regulators on the use of real-world evidence in rare conditions’. Panelist. 13. May 24, 2022. Pharmaceutical Pricing and Market Access, Erasmus University Rotterdam. Rotterdam, The Netherlands. Title: Expanded Access. Guest Lecture. 14. January 30, 2023. CBG and IGJ ‘Science Cafe’. Utrecht, The Netherlands. Title: Pre-approval access to investigational medicine. Invited Speaker. 15. February 20, 2023. Hansen Wade – Operationalize Expanded Access Programs. Title: RealWorld Data: Harnessing Intelligence & Experience. Boston, Massachusetts, USA. Oral. 16. April 26, 2023. Pharmaceutical Pricing and Market Access, Erasmus University Rotterdam. Rotterdam, The Netherlands. Title: Expanded Access. Guest Lecture. 17. April 4, 2023. CQM Seminar Department of Biostatistics and Epidemiology, Erasmus University Rotterdam. Rotterdam, The Netherlands. Title: ‘Augmenting Treatment Arms Through Propensity-Scores and Dynamic Borrowing: An Application to Expanded Access Programs’. Internal Seminar Series. 18. May 25, 2023. World Orphan Drug Congress, Washington DC, USA. Expanded Access (Compassionate Use, Early Access Programs) - Regulatory frameworks, data collection, and global disparities. Closing Keynote Panelist.

RkJQdWJsaXNoZXIy MTk4NDMw